Drug Master Files for: dorzolamide hydrochloride
✉ Email this page to a colleague
dorzolamide hydrochloride Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
18385 | A | II | 5/31/2005 | CRYSTAL PHARMA SAU | DORZOLAMIDE HYDROCHLORIDE |
20284 | I | II | 2/15/2007 | USV LTD | DORZOLAMIDE HYDROCHLORIDE USP |
20441 | A | II | 4/19/2007 | TEVA PHARMACEUTICAL INDUSTRIES LTD | DORZOLAMIDE HCL |
20740 | A | II | 7/27/2007 | FIS FABBRICA ITALIANA SINTETICI SPA | DORZOLAMIDE HYDROCHLORIDE |
20856 | A | II | 9/17/2007 | FDC LTD | DORZOLAMIDE HYDROCHLORIDE USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information